Moore v. Lederle Laboratories

202 N.W.2d 481, 42 Mich. App. 689, 1972 Mich. App. LEXIS 984
CourtMichigan Court of Appeals
DecidedSeptember 26, 1972
DocketDocket 10771
StatusPublished
Cited by5 cases

This text of 202 N.W.2d 481 (Moore v. Lederle Laboratories) is published on Counsel Stack Legal Research, covering Michigan Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Moore v. Lederle Laboratories, 202 N.W.2d 481, 42 Mich. App. 689, 1972 Mich. App. LEXIS 984 (Mich. Ct. App. 1972).

Opinion

Bronson, P. J.

The present appeal requires a determination of a party’s right to object to testimony contained in a deposition offered at trial and is precipitated by the following sequence of events.

Within nine weeks from birth, plaintiff was diagnosed as having the disease cystic fibrosis. He received curative and preventive treatment by the intermittent administration of two antibiotic drugs manufactured by defendant until being placed upon different drugs in 1964. As a consequence of this treatment, plaintiffs teeth became permanently stained blue-black in color and structurally damaged. Plaintiff instituted suit in the Washtenaw County Circuit Court to recover damages for the injurious side-effects of these drugs. Defendant was charged with responsibility for its alleged failure to discover and warn the medical profession of the tooth-staining and damaging propensity of its drugs.

In preparation of its case, plaintiff took the deposition of Dr. Howard Mehaffey. Dr. Mehaffey was a dentist instrumentally involved in a research project which attempted to investigate and evaluate the effect of fluorides upon tooth decay when combined with vitamins. As a by-product of this experiment, Dr. Mehaffey discovered an abnormal incidence of tooth discoloration in the participating children. Further investigation revealed that the discoloration occurred in children *691 who had received treatment with tetracycline drugs. The extent of discoloration and type of tooth damage was compiled, classified, and published in 1965. This report constituted documentation to those reports which had observed this phenomenon as early as 1956. Since tetracycline is the generic term for the two challenged drugs produced by defendant, plaintiff relied upon this deposition to establish the tooth-staining and damaging properties of defendant’s drugs and its knowledge of such facts.

At trial plaintiff offered Dr. Mehaffey’s deposition into evidence but wanted omitted a few statements elicited by defendant on cross-examination which were considered incompetent and irrelevant. Defendant objected to the proposed deletions contending that plaintiff waived any errors or irregularities in the deposition pursuant to GCR 1963, 308.3(1) for failure to object during its taking. The trial judge accepted defendant’s argument and admitted the entire deposition. At the conclusion of trial the jury returned a verdict of no cause of action. Plaintiff appeals, claiming that the trial judge’s admission of the entire deposition constituted reversible error.

During the deposition, plaintiff asked Dr. Mehaffey whether an adult’s teeth would become stained after the administration of a tetracycline drug. This witness answered in the negative based upon his own personal experience. Upon cross-examination of this witness, defendant elicited his conclusion that in spite of the knowledge that tetracyclines caused staining, they are used in exceptional cases where life is threatened. This approach was in accordance with defendant’s theory of the case that the tooth staining was an indigenous disadvantage outweighed by the lifesav *692 ing capabilities of the drug. Defendant pursued this approach by questioning Dr. Mehaffey about his children and whether they had used tetracycline drugs. Dr. Mehaffey answered that his daughter received a tetracycline drug when she had bronchial pneumonia. Defense counsel continued his cross-examination by asking, "How sick was she with that?” Dr. Mehaffey answered that "She could have died within 24 hours had she not been placed on it [the tetracycline drug] immediately”. Thereafter, defense counsel extracted the conclusion from this witness that the tooth staining was worth saving his daughter’s life. At trial plaintiff challenged the admissibility of these statements by the deponent, objecting to their competency and relevancy.

Plaintiff’s challenge is governed by GCR 1963, 308.3(1), which provides:

"Objections to the competency of a witness or to the competency, relevancy, or materiality of testimony are not waived by failure to make them before or during the taking of the deposition, unless the ground of the objection is one which might have been obviated or removed if presented at that tíme. "(Emphasis added.)

This rule was adopted verbatim from Rule 32(d)(3)(A) of the Federal Rules of Civil Procedure. Within the phrase "unless the ground of the objection is one which might have been obviated or removed if presented at that time” lies the requirement dispositive of the present issue. Guidance for interpreting this language is found in Wright & Miller’s treatise on Federal Civil Procedure by their comment:

"What was formerly all of Rule 32 has now been made into subdivision (d) of that rule. Its general principle is to require defects in the taking of depositions to *693 be pointed out promptly on pain of waiver. The purpose is to give the erring party an opportunity to correct the mistake, and to prevent waste of time and money by a subsequent claim that a deposition must be suppressed because of some technical error long ago. The one limited exception to the general rule, found in Rule 32(d)(3)(A), is consistent with this purpose, in that if [sic] provides that objections to competency, relevancy, or materiality that could not have been corrected if made at the time need not be made and are not waived. This provision avoids burdening the deposition with a number of objections. These objections as to defects that could not have been avoided in any event may be made at the trial when and if the deposition is offered. Thus subdivisions (b) and (d) of Rule 32, read together, preserve the important distinction between the broad scope of discovery and its limited use at the trial.” 1

These authors further emphasize the distinction "between objections of substance going to admissibility and formal objections to the form of the question and the conduct of the examination” in § 2156 of their treatise.

It is this distinction which provides a method of defining what is meant by objections which may be obviated or removed if presented during the taking of a deposition. An objection that counsel is leading a deponent or has failed to lay a proper foundation for questions asked falls within the category of formal objections that may be obviated during the taking of the deposition. Elyria-Lorain Broadcasting Co v Lorain Journal Co, 298 F2d 356 (CA 6, 1961); Nutterville v McLam, 84 Idaho 36; 367 P2d 576 (1961); Batelli v Kagan & Gaines Co, 236 F2d 167 (CA 9, 1956). Similarly, an objection that an expert witness’ opinion is based upon hearsay evidence can be cured at the time of taking a deposition by the use of a hypothetical *694 question. Dudding v Thorpe, 47 FRD 565 (WD Pa, 1969); Cordle v Allied Chemical Corp, 309 F2d 821 (CA 6, 1962).

The alternative theory in which an objection cannot be cured at the taking of a deposition is delineated by

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Liliya Komendat v. Andrew Gifford
Michigan Court of Appeals, 2020
Bonelli v. Volkswagen of America, Inc
421 N.W.2d 213 (Michigan Court of Appeals, 1988)
Willerick v. Hanshalli
356 N.W.2d 36 (Michigan Court of Appeals, 1984)
Howell v. King
258 N.W.2d 200 (Michigan Court of Appeals, 1977)
Moore v. Lederle Laboratories
220 N.W.2d 400 (Michigan Supreme Court, 1974)

Cite This Page — Counsel Stack

Bluebook (online)
202 N.W.2d 481, 42 Mich. App. 689, 1972 Mich. App. LEXIS 984, Counsel Stack Legal Research, https://law.counselstack.com/opinion/moore-v-lederle-laboratories-michctapp-1972.